期刊文献+

急性ST段抬高型心肌梗死患者溶栓成功后肌钙蛋白I水平的变化 被引量:8

暂未订购
导出
摘要 目的:观察急性ST段抬高型心肌梗死(STEMI)患者尿激酶(UK)溶栓成功后肌钙蛋白I(CTnI)峰值持续时间的变化规律。方法:分析我院收治的应用UK溶栓成功的STEMI患者89例,同时收集病程在12 h内溶栓未成功的STEMI患者98例,非ST段抬高型心肌梗死(NSTEMI)患者88例,监测CTnI及CK-MB峰值及持续时间。结果:溶栓成功STEMI组患者的CK-MB的峰值时间(18.2±3.6)h,CTnI的峰值时间(23.1±9.8)h,分别较NSTEMI患者的CK-MB的峰值时间(28.1±4.2)h及CTnI的峰值时间(31.4±8.9)h明显缩短(P<0.05);溶栓未成功的STEMI患者的CTnI的峰值时间(39.7±8.0)h,其峰值(12.0±9.4)ng/mL较前2组明显升高(P<0.05)。结论:急性心肌梗死后积极的血管再通治疗能显著减少心肌受损;有效血管再通后可能存在再灌注损伤或延迟,导致心肌再次受损。
出处 《内科急危重症杂志》 2014年第1期44-45,共2页 Journal of Critical Care In Internal Medicine
  • 相关文献

参考文献5

二级参考文献52

  • 1杨艳敏,朱俊,谭慧琼,梁岩,章晏,李建东,刘力生,CREATE中国课题组.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176-2182. 被引量:88
  • 2中国急性冠状动脉综合征多中心临床研究协作组.中国多省市急性冠状动脉综合征住院患者治疗现状与指南差距分析[J].中华心血管病杂志,2005,33(9):789-792. 被引量:47
  • 3李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:195
  • 4DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med, 1980,303:897-902.
  • 5Fletcher AP, Sherry S, Alkjaersig N, et al. The maintenance of a sustained thrombolytie state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest, 1959,38: 1111-1119.
  • 6Fassa AA, Urban P, Radovanovic D, et al. AMIS Plus Investigators. Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry. Heart, 2005, 91:882-888.
  • 7Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol, 2000, 36: 2056-2063.
  • 8Fox KA, Goodman SG, Anderson FA Jr, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur heart J, 2003, 24:1414-1424.
  • 9Fox KA, Cokkinos DV, Deckers J, et al. The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J, 2000, 21 : 1440-1449.
  • 10Hasdai D,Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes ( Euro Heart Survey ACS). Eur Heart J, 2002, 23:1190-1201.

共引文献2307

同被引文献71

  • 1吕滨.把握适应证 用好冠状动脉CT血管造影——2010年美国冠状动脉CT血管造影专家共识的解读[J].中国循环杂志,2012,27(S01):76-80. 被引量:3
  • 2高敬,华琦,桑城,范振兴,王彩荣.1137例急性心肌梗死患者临床表现及超声心动图特点[J].首都医科大学学报,2006,27(5):657-659. 被引量:13
  • 3急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1319
  • 4Majeed F, Miller M. Low high-density lipoprotein cholesterol: an important consideration in coronary heart disease risk assess- ment [J]. Curr Opin Endocrinol Diabetes Obes , 2008, 15 (2): 175 -181.
  • 5Aronson D. Hyperglycemia and the pathobiology of diabetic complications [J]. Adv Cardiol , 2008, 45: 1-16.
  • 6Wang YC, Lo PH, Chang SS, et al. Reduced door-to-balloon times in acute ST - elevation myocardial infarction patients undergoing primary percutaneous coronary intervention [J]. Int J Clin Pract , 2012, 66 (1): 69 -76.
  • 7Chamnarnphol N, Wisaratapong T, Cheevatanakornkul S. Correlation between percutaneous coronary intervention volume, door-to-balloon time and mortality of patients with acute STsegment elevation myocardial infarction [J]. J Med Assoc Thai, 2012, 95 (3): 325 - 329.
  • 8Terkelsen CJ, Serensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention [J]. JAMA, 2010, 304 (7): 763 - 771.
  • 9EI-Menyar A, Zubaid M, AIMahmeed W, et al. Killip classification in patients with acute coronary syndrome: insight from a multicenter registry [J]. Am J Emerg Med, 2012, 30 (1): 97 -103.
  • 10Stebbins A, Mehta RH, Armstrong PW, et al. A model for prediction mortality in acute ST - segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial [J]. Circ Cardiovasc Interv , 2010, 3 (5): 414 - 422.

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部